|
HS Code |
951789 |
| Organism | Vibrio natriegens |
| Type | Gram-negative bacterium |
| Shape | Curved rod (vibrio) |
| Motility | Motile with flagella |
| Doubling Time | Less than 10 minutes under optimal conditions |
| Optimal Temperature | 30-37°C |
| Halophilic | Requires salt, typically 1.5% NaCl |
| Genome Size | Approximately 5.17 Mbp |
| Natural Habitat | Marine environments |
| Application | Used for rapid recombinant protein production |
| Oxygen Requirement | Facultative anaerobe |
| Ph Range | 6.5-9.0 |
As an accredited Vibrio Natriegens factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sterile 1g vial of **Vibrio natriegens** freeze-dried culture; clear glass bottle with tamper-evident seal and product labeling. |
| Shipping | **Vibrio natriegens** is shipped as a lyophilized culture or on an agar slant within a secure, leak-proof container. The package is clearly labeled in compliance with biosafety regulations (BSL-1), ensuring safe handling and quick delivery. Shipping usually requires ambient temperature, with expedited services recommended for strain viability. |
| Storage | Vibrio natriegens should be stored as a glycerol stock at -80°C for long-term preservation. For short-term storage, bacterial cultures can be kept on appropriate agar plates at 4°C. Ensure all storage containers are clearly labeled and tightly sealed to prevent contamination or desiccation. Strict aseptic techniques must be followed when handling to maintain strain integrity and viability. |
|
High Growth Rate: Vibrio Natriegens with a doubling time of less than 10 minutes is used in recombinant protein production, where rapid biomass accumulation significantly increases yield efficiency. Purity 99%: Vibrio Natriegens of 99% purity is used in plasmid DNA amplification, where high purity ensures minimized contamination and reliable downstream processing. Salt Tolerance 3% NaCl: Vibrio Natriegens with 3% NaCl tolerance is used in high-salt bioprocessing, where robust survival enables successful fermentation under saline conditions. Transformation Efficiency 1x10^9 CFU/μg DNA: Vibrio Natriegens with high transformation efficiency is used in genetic engineering workflows, where maximized uptake of plasmid DNA accelerates cloning applications. Stable at 37°C: Vibrio Natriegens with stability at 37°C is used in continuous bioreactor cultures, where optimal thermal tolerance supports consistent production rates. Molecular Weight 2.4 fg/cell: Vibrio Natriegens with a molecular weight of 2.4 femtograms per cell is used in cell-based assay development, where small cell size enables high-density experimental designs. Glycerol Stock Viability >95%: Vibrio Natriegens with glycerol stock viability greater than 95% is used in long-term strain preservation, where high viability supports repeated and reliable culture revival. Plasmid Stability >90% Retention: Vibrio Natriegens with greater than 90% plasmid stability is used in synthetic biology constructs, where stable maintenance of genetic elements enhances experimental reproducibility. Protein Expression Level >200 mg/L: Vibrio Natriegens expressing protein at levels greater than 200 mg/L is used in industrial enzyme manufacturing, where high expression rates streamline product recovery. Growth in Minimal Media: Vibrio Natriegens capable of growth in minimal media is used in metabolic engineering studies, where controlled nutrient environments facilitate pathway optimization. |
Competitive Vibrio Natriegens prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of work in microbial manufacturing have shown us that Vibrio natriegens holds a special role in the development of biotechnology. This gram-negative, non-pathogenic bacterium naturally occurs in estuarine and marine environments. Its most surprising feature quickly becomes obvious in the fermenter: it grows with astounding speed. Doubling times under rich media hover around 10 minutes, putting it on a different playing field. Compared to the well-worn workhorse Escherichia coli, which usually needs about 20 minutes for one cycle, Vibrio natriegens is in a class of its own. That palpable difference on the production line matters. Very few microbes come close.
Our story with Vibrio natriegens began at the benches. While most labs stuck to their tried-and-true E. coli stocks, we needed a microbe that could do more with less time. Before bringing a new strain online, we compared fermentation outputs every step of the way. With Vibrio natriegens, live culture densities rose up to six times faster under matched conditions. That head start means process engineers can cut wait times and ramp to mid or high cell densities in hours, not days.
Production teams seek this advantage not only for speed, but for efficiency. Extended fermentation often brings cross-contamination, power hungry cooling, and gradual yield declines as the media tires out. Tapping into rapid bacterial growth makes every fermenter run that much more reliable. Less risk of stalled or oxygen-starved cultures means less batch failure. For labs, the difference translates directly to faster data returns and project cycles. Operations benefit from the consistent structure of Vibrio natriegens, with fewer surprises from genetic or morphological drift across passages.
In industrial applications, details matter. Our Vibrio natriegens models have resulted from careful strain selection and thorough performance screens. Factory teams have worked out the subtleties of various strains—you find that some variants grow exceptionally in media rich in peptones, while others reach higher biomass in salts and minimal nutrient bases. This flexibility lets R&D projects fine-tune protocol, so the organism fits both basic research and pilot-scale biomanufacturing goals.
The strains we recommend typically thrive in temperatures between 30 and 37°C. NaCl concentrations need to be considered: Vibrio natriegens responds best to 1-2% NaCl, echoing its natural saltwater lineage. Early mistakes in media design can halve the yield, so we share our tested formulas. Aerobic fermentation yields sharp doubling times, but it also tolerates moderate microaerophilic or anaerobic conditions when specific metabolites are targeted for extraction.
Our upstream development team keeps plasmid compatibility as a core focus. Recent protocols allow most standard vectors used in E. coli to replicate in Vibrio natriegens after minor adjustment. Selections based on kanamycin or ampicillin work reliably, making the transfer from legacy E. coli workflows to this new system nearly seamless for users. This compatibility allows researchers to use existing genetic tools with minor changes, reducing barriers for in-house innovation.
Walking into the process hall, the difference between a Vibrio natriegens run and that of other species is immediate. Microbial protein production—perhaps the backbone of biomanufacturing—requires massive culture volumes and tight schedule discipline. Time becomes expensive when scheduling fermenter turns, cleaning, and raw material use. When a strain on average completes six generations before others even reach three, the impact is not theoretical. We've shown in head-to-head plant tests that Vibrio natriegens lets lines run shorter, skip extra inoculation cycles, and meet downstream deadlines more simply.
For recombinant protein, enzyme, and specialty chemical development, the benefits continue downstream. The organism copes well with high-density production, and oxygen demand per biomass unit stands lower than some fast-growing Gram-negatives. We have engineered pilot protocols to sustain Vibrio natriegens at optical densities above 50, delivering grams-per-liter yields while containing costs. Speed does not just shave hours—it rewrites process economics.
E. coli has built a long legacy in biotechnology for its predictability and legacy toolkit. Many industrial teams still prefer its “tried, tested, and true” status for complex protein or easy scale-up, especially where regulatory familiarity counts. Yet, for many applications, E. coli shows limitations. Toxic gene products suppress E. coli’s metabolism, reducing final yields or derailing scale-up. Vibrio natriegens tolerates greater metabolic demands before plateauing. The same gene inserts that collapse E. coli culture density can push Vibrio natriegens to high titers, slashing the need for optimization cycles.
Bacillus subtilis and Pseudomonas putida fill their own niches, from enzyme secretion to pollutant degradation. We’ve benchmarked Vibrio natriegens against each. In most side-by-sides, it doubles the speed of Bacillus runs and easily outpaces Pseudomonas for biomass. Unlike those alternatives, Vibrio natriegens works with standard salt-based media and keeps cell wall structure suitable for common lysis approaches, which matters massively for teams optimizing protein purification.
Vibrio natriegens already supports a wide span of projects here. Most of our collaborators seek it for rapid recombinant protein screening, metabolic engineering, and high-throughput cloning. The fast doubling rate means CRISPR-based editing or pathway testing happens without multi-day delays. A team optimizing an antibiotic biosynthesis pathway will see a week’s cycle collapsed into less than three days, with more data points per experiment.
Across food, feed, and specialty chemical production, Vibrio natriegens becomes valuable for fast-tracking strain design and fermentation analytics. For those working on enzyme development, faster culturing means more candidate enzymes screened per unit time, speeding up the talent pipeline in house. Synthetic biology groups increasingly build entire pathways within Vibrio natriegens before porting them to slower, more traditional hosts for final validation.
Vibrio natriegens shows resilience to osmotic and oxidative stress that matches the best production strains. Its robust cell envelope resists many types of mechanical shear, so scale from bench to pilot line needs less retooling. This characteristic cuts hidden overhead for large-batch protein or specialty metabolite production.
Our experience tells us that an organism truly excels not only by growing fast, but by allowing precise genetic control. Advanced transformation protocols developed for Vibrio natriegens now rival the ease of E. coli’s historic methods. Whether for electroporation or chemical transformation, the success rates reach impressive levels, showing nearly 108 transformants per microgram under optimized conditions.
Looking deeper, several teams have reported lower background expression and sharper induction with established control elements. For those engineering tight switches or high-value products, this attribute delivers cleaner, more predictable batches. Synthetic biologists working with large pathway assemblies appreciate this trait, since low-leak expression helps maintain cell health and maximize target output.
Working on synthetic pathways, we have converted vectors, standardized replicons, and demonstrated markerless editing. Fine-tuned CRISPR/Cas applications in Vibrio natriegens allow modular genome edits in days, supporting industrial strain improvement cycles that keep pace with market demand.
Supplying Vibrio natriegens presents unique challenges and opportunities for control over quality. Unlike commodity cell banks, Vibrio natriegens stocks require careful cold chain maintenance and batch-level genetic validation. Our in-house approach focuses on producing verified, contamination-free cultures from single colony isolation, grown in certified clean rooms under constant microbial monitoring. This quality protocol evolved because many production strains can drift genetically if stored poorly or subcultured too often. By providing robust seed stocks year-round, our partners enjoy reliability and consistency in every fermentation, without concern for off-target productivity decline.
Supply reliability supports uninterrupted research cycles, especially for high-output teams. We understand this risk because an entire run can fall apart if the starting culture leaves room for entry by a slower-growing contaminant strain. Vigilant batch control and comprehensive recordkeeping at our end mean downstream teams spend less time troubleshooting outlier runs.
Most industrial groups we work with ask about safety, differentiation, and compliance before onboarding a new organism. Vibrio natriegens stands out with its low pathogenicity and absence of known toxins or virulence factors. Regulatory frameworks classify it generally as a biosafety level 1 organism. Our quality team still maintains documentation for traceability and supports teams implementing good manufacturing practices in clinical or dietary projects, where regulatory scrutiny sits highest.
In R&D or pilot environments, the lightweight biosafety footprint of Vibrio natriegens allows teams to operate with fewer restrictions. This practicality speeds project setup, lowers training burdens, and reduces costs tied to containment. In global supply discussions, this compliance record can smooth import and export for multinational groups relying on cross-border collaboration.
Feedback from public and private sector partners influences every round of product refinement. Initial hesitation about switching microbial platforms has waned as more labs document clear cost and schedule gains. In one collaborative project with a pharmaceutical innovator, switching from E. coli to Vibrio natriegens shortened fermentation step times by two-thirds, raising average protein yields by over 30%. Field teams reported cleaner harvests and fewer batch reworks, reducing risk across the production line.
The agriculture and feed sectors noted the time savings for microbial protein concentrate and single-cell protein runs. Quality managers mentioned a sharper protein profile and fewer off-flavor metabolites—an effect we traced back to the distinct carbon metabolism of Vibrio natriegens. Engineers trialing the system for biosurfactant development recorded less foaming and faster batch turns, cutting operational downtimes significantly.
Moving away from the literature and into the plant reveals the quirky sides of rapid-growing microbes. Rapid sulfur and phosphate depletion happens more often during overnight batch culture, sometimes leading to unexpected lag phases if teams neglect media supplementation. Our process operators recognize the importance of monitoring ion levels, especially magnesium and potassium, for cultures exceeding 20 hours in volume fermenters. Small ingredient changes in media composition influence yield by as much as 20%, so our line workers conduct pilot checks with each major formula shift.
Scaling to high-density culture sometimes brings oxygen transfer limitations. Fermenter design matters; flat-bottom bioreactors with optimized headspace aeration outperform deep-cone systems. Autoinduction protocols benefit from increased trace mineral supplies and staged nutrient feeds. Process automation has helped us capture the culture’s exponential window, harvesting before stress signals rise. For teams new to Vibrio natriegens, we recommend simple feedback loops that track optical density and pH every hour during transition growth stages.
Teaching new teams about Vibrio natriegens shifts the ramp-up curve. To provide direct support, our technical group offers in-house seminars, virtual walkthroughs, and tailored SOPs that bridge legacy E. coli protocols to Vibrio natriegens workflows. On-site troubleshooting pinpoints the small decisions that prevent lags or metabolic stalls. As part of our partnership model, we share updated data on best practices, proven feed formulations, and high-yield vector options.
Our field engineers help scale up from microplate to pilot fermenters, recommending process management tools to ensure every run gets maximum output in minimal time. This hands-on approach has proven more effective than detailed but generic protocol sheets. Teams swapping to Vibrio natriegens often see efficiency rise within weeks, not months.
We run the full manufacturing process for Vibrio natriegens, not just distribution. Research, improvement, and production roll out under one set of standards. By keeping development, QA, and downstream application support under one roof, we spot problems early. Controlling the whole cycle—from seed stock to final culture preparation—protects every order from contamination and genetic drift.
Consistent batch verification remains our anchor. By embedding high-throughput screening and genetic barcoding at the seed stage, we respond quickly to evolutionary changes that would cause output drops. Our in-house analytics routinely scan for unintended mutations, not relying only on phenotype checks. This catch-and-correct approach reduces burden for customers who rely on predictable performance.
As manufacturing scale grows, challenges evolve. Regulatory environments continuously change, and documentation standards rise in complexity. Strain adaptation to new feedstocks, alternative energy sources, or advanced metabolic pathways will push teams to integrate new monitoring and process control technology. We prepare our manufacturing lines for these shifts with investment in automation, digital analytics, and diversity in media supply sources.
Environmental responsibility shapes more decisions in biomanufacturing. Our teams work to source sustainable nutrient supplies for Vibrio natriegens fermentation and push for closed-loop water recovery. Minimizing waste and spent media discharge makes a difference at any manufacturing scale, especially with high-output organisms that process volumes at record speeds.
Collaboration bridges the last gaps in the adoption curve. By maintaining expert relationships with academic groups, platform technology companies, and regulatory consultants, we keep up with both technical and compliance advancement. Bringing Vibrio natriegens to more teams means ongoing effort to train, inform, and update every user group to realize its full, safe, and productive potential.
Handling Vibrio natriegens from the manufacturing floor to the customer’s incubator gives a clear picture of its value for biotech and industrial teams. The organism eliminates unnecessary waiting, supports higher titers, and remains flexible for evolving project goals. While legacy strains will continue to fill important roles, Vibrio natriegens offers a distinct edge for speed, reliability, and innovation.
Practical manufacturing experience shows the difference between speculative claims and applied value. For us, every culture batch delivered, every yield boost achieved, every troubleshooting session resolved—these moments confirm why Vibrio natriegens sits at the center of next-generation bioprocessing. By staying focused on continuous improvement, transparent support, and responsible stewardship, we help researchers, product developers, and industrial producers harness the power of this remarkable organism where it can do the most good.
